Compositions comprising cinnamaldehyde and zinc and methods of using such compositions
US-10092028-B2 · Oct 9, 2018 · US
US11110120B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11110120-B2 |
| Application number | US-201615573562-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 24, 2016 |
| Priority date | Jun 5, 2015 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The cinnamaldehyde is supplemented by zinc, and the combination can be effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight management or promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory. The composition can achieve a therapeutic effect selected from the group consisting of blood vessel dilation, reduced blood pressure, increased delivery of blood flow to tissues in the body, stimulation of protein synthesis, increased release of growth factors, enhanced immune function, and combinations thereof.
Opening claim text (preview).
The invention is claimed as follows: 1. A method for treating or reducing a risk and/or a severity of high blood pressure, the method comprising administering a food product to a human in need thereof and who is not obese or overweight, the food product comprising cinnamaldehyde and zinc in a cinnamaldehyde:zinc ratio in molarity of 1:0.5 to 1:0.005, the food product is selected from the group consisting of a beverage, a cereal bar, a dairy bar, a soup, a breakfast cereal, muesli, a candy, a cookie, a biscuit, a cracker, a dairy product, a tablet, a capsule, a pastille and a liquid, the food product comprising the cinnamaldehyde at a flavoring concentration of from 31.87 ppm to 6191 ppm, and the food product comprises at least one of zinc chloride, zinc sulfate, zinc lactate or zinc citrate that provides at least a portion of the zinc. 2. The method of claim 1 , wherein the food product is administered to the human at least once a day for at least one week. 3. The method of claim 1 , wherein the cinnamaldehyde:zinc ratio in molarity is 1:0.03. 4. The method of claim 1 , wherein at least a portion of the cinnamaldehyde is at least one of isolated cinnamaldehyde or chemically synthesized cinnamaldehyde. 5. The method of claim 1 , wherein the cinnamaldehyde:zinc ratio in molarity is about 1:0.03.
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Aldehydes · CPC title
Inorganic salts, minerals or trace elements · CPC title
Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title
Zinc; Compounds thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.